126 related articles for article (PubMed ID: 91600)
1. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase.
Lehnert S
Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):825-33. PubMed ID: 91600
[No Abstract] [Full Text] [Related]
2. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Glass WF; Moore JB
Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
[No Abstract] [Full Text] [Related]
3. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
Manganiello V; Degerman E; Elks M
Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
[No Abstract] [Full Text] [Related]
4. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
Bocek RM; Beatty CH
Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071
[No Abstract] [Full Text] [Related]
5. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
Francis DL; Roy AC; Collier HO
Life Sci; 1975 Jun; 16(12):1901-6. PubMed ID: 168452
[No Abstract] [Full Text] [Related]
6. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
Shechter Y
Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin, and carbachol on pancreatic acini.
Gardner JD; Sutliff VE; Walker MD; Jensen RT
Am J Physiol; 1983 Nov; 245(5 Pt 1):G676-80. PubMed ID: 6195928
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
Wells JN; Kramer GL
Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
[No Abstract] [Full Text] [Related]
9. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini.
Gardner JD; Korman LY; Walker MD; Sutliff VE
Am J Physiol; 1982 Jun; 242(6):G547-51. PubMed ID: 6178297
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture.
Prasad KN; Sakamoto A
Experientia; 1978 Dec; 34(12):1575-6. PubMed ID: 215447
[TBL] [Abstract][Full Text] [Related]
11. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
Cherry JA; Thompson BE; Pho V
Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
Adachi K; Numano F
Jpn J Pharmacol; 1977 Feb; 27(1):97-103. PubMed ID: 194077
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
Polson JB; Krzanowski JJ; Anderson WH; Fitzpatrick DF; Hwang DP; Szentivanyi A
Biochem Pharmacol; 1979 Apr; 28(8):1391-5. PubMed ID: 87201
[No Abstract] [Full Text] [Related]
14. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
Prasad KN; Becker G; Tripathy K
Proc Soc Exp Biol Med; 1975 Jul; 149(3):757-62. PubMed ID: 167381
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
Zhu WH; Majluf-Cruz A; Omburo GA
Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 3',5'-nucleotide phosphodiesterase and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo.
Nahorski SR; Rogers KJ
Neuropharmacology; 1976 Oct; 15(10):609-12. PubMed ID: 186725
[No Abstract] [Full Text] [Related]
17. Partial purification of adenosine 3',5'-cyclic monophosphate phosphodiesterases from rat pancreas in the presence of excess protease inhibitors.
Terai M; Furihata C; Matsushima T; Sugimura T
Arch Biochem Biophys; 1976 Oct; 176(2):621-9. PubMed ID: 185966
[No Abstract] [Full Text] [Related]
18. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
Schwabe U; Miyake M; Ohga Y; Daly JW
Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
[No Abstract] [Full Text] [Related]
19. Anagrelide: a potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity.
Gillespie E
Biochem Pharmacol; 1988 Jul; 37(14):2866-8. PubMed ID: 2456068
[No Abstract] [Full Text] [Related]
20. The involvement of a calmodulin-dependent phosphodiesterase in the negative control of carbamylcholine on cyclic AMP levels in dog thyroid slices.
Miot F; Dumont JE; Erneux C
FEBS Lett; 1983 Jan; 151(2):273-6. PubMed ID: 6187601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
